|
|
Volume 65 Number 5&6 October/November 1998 |
back to contents |
|
|
|
| Oral Cancer and Oral Effects of Anticancer Therapy | 370 |
Andrei Barasch, D.M.D., M.D.Sc.1, Monika Safford, M.D.2, And Ellen Eisenberg, D.M.D.3 |
|
|
From the Departments of 1Dental Medicine and
2Medicine, New Jersey Dental
School, University of Medicine and Dentistry of New Jersey, Newark, NJ,
and 3Department of Oral Diagnosis, University of Connecticut
School of Dental Medicine, Farmington, CT. 1Assistant Professor;
2Assistant
Professor; 3Professor and Director of Oral Pathology.
Address correspondence to Andrei Barasch, D.M.D., M.D.Sc., University of Medicine and Dentistry of New Jersey, New Jersey Dental School, Room C 829, 110 Bergen Street, Newark, NJ 07103-2400. |
ABSTRACT
The term "oral cancer" generally refers to squamous cell carcinoma of
oral mucosal origin, which accounts for more than 90% of all malignancies
of this location. Although a relatively uncommon disease in the United
States, this malignancy is nonetheless important, as it accounts for
significant morbidity and mortality. Approximately half of the estimated
30 thousand cases diagnosed annually in this country have a fatal
outcome. Survivors of the surgical and medical management may suffer
from sequelae of treatment ranging from pain and infection to partial or
total disfigurement and loss of stomatognathic function. Such high
morbidity and mortality are truly regrettable, since many of these
malignancies are preventable. This article will review recent
developments in the epidemiology, treatment and chemoprevention of oral
squamous cell carcinoma as they relate to early diagnosis, and management
of the oral cancer patient.
KEY WORDS
Mouth,
cancer,
chemotherapy,
etiology,
epidemiology,
radiation
| |
MSSM Home | Back Issues | Indexes | Search | Journal Home | |